Literature DB >> 26852865

Increased Systemic Exposure of Methotrexate by a Polyphenol-Rich Herb via Modulation on Efflux Transporters Multidrug Resistance-Associated Protein 2 and Breast Cancer Resistance Protein.

Chung-Ping Yu1, Yun-Chung Hsieh2, Chi-Sheng Shia1, Pei-Wen Hsu1, Jen-Yuan Chen3, Yu-Chi Hou4, Yo-Wen Hsieh5.   

Abstract

Scutellariae radix (SR, roots of Scutellaria baicalensis Georgi), a popular Chinese medicine, contains plenty of flavonoids such as baicalin, wogonoside, baicalein, and wogonin. Methotrexate (MTX), an important immunosuppressant with a narrow therapeutic index, is a substrate of multidrug resistance-associated proteins (MRPs) and breast cancer resistance protein (BCRP). This study investigated the effect of SR on MTX pharmacokinetics and the underlying mechanisms. Rats were orally administered MTX alone and with 1.0 or 2.0 g/kg of SR. The serum concentrations of MTX were determined by a fluorescence polarization immunoassay. Cell models were used to explore the involvement of MRP2 and BCRP in the interaction. The results showed that 1.0 g/kg of SR significantly increased Cmax, AUC(0-30), AUC(0-2880), and mean residence time (MRT) of MTX by 50%, 45%, 501%, and 347%, respectively, and 2.0 g/kg of SR significantly enhanced the AUC(0-2880) and MRT by 242% and 293%, respectively, but decreased AUC(0-30) by 41%. Cell line studies indicated that SR activated the BCRP-mediated efflux transport, whereas the serum metabolites of SR inhibited both the BCRP- and MRP2-mediated efflux transports. In conclusion, SR ingestion increased the systemic exposure and MRT of MTX via modulation on MRP2 and BCRP.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BCRP; MRP2; herb-drug interaction; methotrexate; scutellariae radix

Mesh:

Substances:

Year:  2016        PMID: 26852865     DOI: 10.1016/j.xphs.2015.11.031

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.

Authors:  Chao Hong; Dan Wang; Jianming Liang; Yizhen Guo; Ying Zhu; Jiaxuan Xia; Jing Qin; Huaxing Zhan; Jianxin Wang
Journal:  Theranostics       Date:  2019-06-09       Impact factor: 11.556

2.  Evaluation of the Mrp2-mediated flavonoid-drug interaction potential of quercetin in rats and in vitro models.

Authors:  Ju-Hee Oh; Joo Hyun Lee; Young-Joo Lee
Journal:  Asian J Pharm Sci       Date:  2019-01-16       Impact factor: 6.598

3.  Exploring the Mechanism of Baicalin Intervention in Breast Cancer Based on MicroRNA Microarrays and Bioinformatics Strategies.

Authors:  Anqi Ge; Lifang Liu; Xian'guang Deng; Jun Luo; Yanghua Xu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-20       Impact factor: 2.629

4.  Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration.

Authors:  Chung-Ping Yu; Pei-Ying Li; Szu-Yu Chen; Shiuan-Pey Lin; Yu-Chi Hou
Journal:  Molecules       Date:  2021-12-06       Impact factor: 4.411

5.  Design and Characterization of Liposomal Methotrexate and Its Effect on BT-474 Breast Cancer Cell Line.

Authors:  Niloufar Tavakoli Dastjerd; Nematollah Gheibi; Hossein Ahmadpour Yazdi; Hanifeh Shariatifar; Alireza Farasat
Journal:  Med J Islam Repub Iran       Date:  2021-11-29

6.  Screening of cytoprotectors against methotrexate-induced cytogenotoxicity from bioactive phytochemicals.

Authors:  Shaobin Gu; Ying Wu; Jianbo Yang
Journal:  PeerJ       Date:  2016-05-11       Impact factor: 2.984

7.  Transporter-mediated interaction of indican and methotrexate in rats.

Authors:  Shiuan-Pey Lin; Chung-Ping Yu; Yu-Chi Hou; Ching-Ya Huang; Lu-Ching Ho; Shu-Ling Chan
Journal:  J Food Drug Anal       Date:  2017-12-14       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.